These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1659902)

  • 1. Limited cytomegalovirus-specific immunoglobulin M and immunoglobulin G profiles in heart transplant recipients.
    Allen MD; Denny CF; Kruse AP; Revkin JH; Fishbein DP; Ashley RL
    J Heart Lung Transplant; 1991; 10(5 Pt 1):664-73. PubMed ID: 1659902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
    Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
    J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
    Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
    J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
    Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
    J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications of infections attributed to cytomegalovirus in a group of 52 kidney transplant patients].
    Galezowski N; Godeaut E; Berche P; Bonissol C; Debure A; Kreis H
    Ann Med Interne (Paris); 1987; 138(5):369-71. PubMed ID: 2823666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
    Milbradt H; Flik J; Stangel W; Heigel R
    Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
    Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
    Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of cytomegalovirus infection following human heart-lung transplantation.
    Burke CM; Glanville AR; Macoviak JA; O'Connell BM; Tazelaar HD; Baldwin JC; Jamieson SW; Theodore J
    J Heart Transplant; 1986; 5(4):267-72. PubMed ID: 3040942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical course of cytomegalovirus infection in renal transplant recipients].
    Luchsinger V; Suárez M; Montiel F; Kaltwasser G
    Rev Med Chil; 1999 Jan; 127(1):9-17. PubMed ID: 10436673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status.
    Lutz E; Ward KN; Szydlo R; Goldman JM
    J Med Virol; 1996 May; 49(1):61-5. PubMed ID: 8732861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
    Eichler C; Kaden J; May G
    Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
    Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year experience with human cytomegalovirus infections in heart transplant recipients.
    Grossi P; Revello MG; Minoli L; Percivalle E; Zavattoni M; Poma G; Martinelli L; Gerna G
    J Heart Transplant; 1990; 9(6):712-9. PubMed ID: 2177498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mono- and oligoclonal immunoglobulin anomalies in kidney transplant patients].
    Cakalaroski K; Ivanovski N; Popov Z; Dohcev S; Kolevski P; Weil B; Lang P
    Ann Urol (Paris); 2000 Oct; 34(5):340-4. PubMed ID: 11144723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG monitoring to identify the risk for development of infection in heart transplant recipients.
    Sarmiento E; Rodriguez-Molina JJ; Fernandez-Yañez J; Palomo J; Urrea R; Muñoz P; Bouza E; Fernandez-Cruz E; Carbone J
    Transpl Infect Dis; 2006 Mar; 8(1):49-53. PubMed ID: 16623821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serologic diagnosis of cytomegalic inclusion disease using the Elisa technic in kidney transplant patients].
    Dennin RH; Herhan J; Schulz E; Sack K
    Dtsch Med Wochenschr; 1984 Feb; 109(6):214-6. PubMed ID: 6321127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific IgM of cytomegaloviruses and primary infection in kidney transplant patients].
    Devillechabrolle A; Nguyen TT; Luciani J; Frantz P; Huraux JM
    Pathol Biol (Paris); 1987 Oct; 35(8):1123-6. PubMed ID: 2825100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive predictive value of anti-HCMV IgM as an index of primary infection.
    De Paschale M; Agrappi C; Manco MT; Clerici P
    J Virol Methods; 2010 Sep; 168(1-2):121-5. PubMed ID: 20470827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.